News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Elevar Therapeutics Receives Orphan Drug Status from EMA for First-Line Therapy in Unresectable Hepatocellular Carcinoma
Friday, August 02, 2024Elevar Therapeutics Inc a majorityowned subsidiary of HLB Co Ltd has received Orphan Medicinal Product Designation from the European Medicines Agency EMA for rivoceranib in combination
Rejuvenate Biomed and SAS Collaborate on AI-Driven Tools for Disease-Agnostic Drug Repurposing
Friday, August 02, 2024Rejuvenate Biomed and SAS have announced a strategic partnership to create a new userfriendly tool for drug repurposing This innovative tool will help researchers and scientists uncover critical insights
Novo Holdings Acquires Stake in Oxford Nanopore Technologies, a UK-Listed Firm
Friday, August 02, 2024Novo Holdings a leading global life science investor has announced a million investment in Oxford Nanopore Technologies This investment part of a new equity issue is expected to be complemented
Taiho Oncology Europe Launches Lytgobi® (Futibatinib) in Spain for Cholangiocarcinoma Therapy
Friday, August 02, 2024Taiho Oncology Europe GmbH has introduced Lytgobi in Spain following its conditional marketing authorization in the European Union This innovative drug is a nonreversibly binding fibroblast growth
Avicenna Biosciences and Molecure S.A. Form Strategic Collaboration to Boost Small Molecule Drug Development
Thursday, August 01, 2024Molecure SA and Avicenna Biosciences Inc have announced a strategic research partnership to develop novel small molecule drugs targeting ubiquitinspecific protease a deubiquitinase linked
Halia Therapeutics and Biolexis Therapeutics Announce Key Breakthrough in Neuroinflammation Research
Thursday, August 01, 2024Halia Therapeutics a biopharmaceutical company focused on novel small molecule therapies for inflammation and Biolexis Therapeutics known for its AIdriven drug discovery have announced a significant advancement in their collaboration
Leveragen Forms Collaboration with Moderna to Enhance Therapeutics Using Unique Fully Human Single Domain Antibody Technology
Wednesday, July 31, 2024Leveragen Inc a Bostonbased biotech startup has announced a new multitarget research option and license agreement with Moderna Inc Leveragen will use its proprietary single domain antibody discovery
Verseon and NeuTherX Partner to Boost Drug Development Efforts
Wednesday, July 31, 2024Verseon and NeuTherX are thrilled to announce a new partnership designed to enhance drug development through NeuTherXs advanced organoid cultivation technology Verseon is committed to refining the drug development process focusing on creating treatme...
Boehringer Ingelheim Expands Portfolio with Acquisition of Nerio Therapeutics' Immune Checkpoint Inhibitor
Tuesday, July 30, 2024Boehringer Ingelheim has made a major advancement in its immunooncology pipeline by acquiring Nerio Therapeutics Inc for up to USD billion This acquisition
Inductive Bio Announces Successful Outcomes from Drug Optimization Collaboration with Nested Therapeutics
Tuesday, July 30, 2024Inductive Bio a pioneer in utilizing machine learning ML to advance small molecule drug discovery has shared new insights from their recent collaboration with Nested Therapeutics Nested recognized
